Testing effectiveness (Phase 2)Study completedNCT02128113
What this trial is testing
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
Who this might be right for
Corneal Endothelial Cell LossOcular PainOcular Inflammation+1 more
Biogen 307